SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-002157
Filing Date
2019-03-01
Accepted
2019-03-01 11:05:38
Documents
13
Period of Report
2019-03-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cbmg_8k.htm 8-K 25373
2 PRESENTATION cbmg_ex991.htm EX-99.1 10373
3 IMAGE cbmg_ex991000.jpg GRAPHIC 105792
4 IMAGE cbmg_ex991001.jpg GRAPHIC 258639
5 IMAGE cbmg_ex991002.jpg GRAPHIC 93585
6 IMAGE cbmg_ex991003.jpg GRAPHIC 140589
7 IMAGE cbmg_ex991004.jpg GRAPHIC 109255
8 IMAGE cbmg_ex991005.jpg GRAPHIC 136777
9 IMAGE cbmg_ex991006.jpg GRAPHIC 86541
10 IMAGE cbmg_ex991007.jpg GRAPHIC 137964
11 IMAGE cbmg_ex991008.jpg GRAPHIC 131702
12 IMAGE cbmg_ex991009.jpg GRAPHIC 136076
13 IMAGE cbmg_ex991010.jpg GRAPHIC 74162
  Complete submission text file 0001654954-19-002157.txt   1981509
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (347) 905 5663
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36498 | Film No.: 19647374
SIC: 2836 Biological Products, (No Diagnostic Substances)